The idea behind a successful vaccine supplier is that there...

The idea behind a successful vaccine supplier is that there should be a lesser future need to treat the thingy you have been vaccinated against!

What a conflict of interest! You’re right Subi1, if a decent partnership agreement cannot be found, they might as well consider going forward with their existing partner Daiichi Sangko, and perhaps with Ranbaxy as the producer and marketer for the product. Surely they can handle and efficiently service the 60 odd known government stockpilers already established and open up the private sector market to other interested pharma companies, on a regional basis if necessary.

The sum of the parts can become much bigger than the whole!